Characterization of a novel human anti-GD2 anti-idiotypic antibody GK8 DNA vaccine for immunotherapy in neuroblastoma

被引：0
|
作者：
Weixler, S. [1 ]
Fest, S. [1 ]
Huebener, N. [1 ]
Kruger, J. [1 ]
Gaedicke, G. [1 ]
Lode, H. [1 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
来源：
ACTA PAEDIATRICA | 2008年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [31] Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Tarek, Nidale
    Le Luduec, Jean-Benoit
    Gallagher, Meighan M.
    Zheng, Junting
    Venstrom, Jeffrey M.
    Chamberlain, Elizabeth
    Modak, Shakeel
    Heller, Glenn
    Dupont, Bo
    Cheung, Nai-Kong V.
    Hsu, Katharine C.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (09): : 3260 - 3270
  • [32] INVITRO MANIPULATION OF HUMAN ANTI-DNA ANTIBODY-PRODUCTION BY ANTI-IDIOTYPIC ANTIBODIES CONJUGATED WITH NEOCARZINOSTATIN
    SASAKI, T
    TAMATE, E
    MURYOI, T
    TAKAI, O
    YOSHINAGA, K
    JOURNAL OF IMMUNOLOGY, 1989, 142 (04): : 1159 - 1165
  • [33] Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine?
    Gach, Johannes S.
    Quendler, Heribert
    Weik, Robert
    Katinger, Hermann
    Kunert, Renate
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (11) : 1405 - 1415
  • [34] Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy
    Kushner, Brian H.
    LaQuaglia, Michael P.
    Cardenas, Fiorella Iglesias
    Basu, Ellen M.
    Gerstle, Justin T.
    Kramer, Kim
    Roberts, Stephen S.
    Wolden, Suzanne L.
    Cheung, Nai-Kong V.
    Modak, Shakeel
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (12) : 2019 - 2031
  • [35] Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy
    Kushner, Brian H.
    Modak, Shakeel
    LaQuaglia, Michael P.
    Basu, Ellen M.
    Gerstle, Justin T.
    Cardenas, Fiorella Iglesias
    Kramer, Kim
    Roberts, Stephen S.
    Wolden, Suzanne L.
    Cheung, Nai-Kong V.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Modulating anti-GD2 immunotherapy via dual DFMO and TGF-β inhibition in neuroblastoma
    Gandhi, Om H.
    Turn, Christina S.
    Liu, Kangning
    Vu, Annette T.
    Bassiri, Hamid
    Hogarty, Michael D.
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
    Liu, Xiaoming
    Wills, Carson A.
    Chen, Longgui
    Zhang, Jiawen
    Zhao, Yuanjun
    Zhou, Mi
    Sundstrom, Jeffrey M.
    Schell, Todd
    Spiegelman, Vladimir S.
    Young, Megan M.
    Wang, Hong-Gang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)
  • [38] SINUSOIDAL OBSTRUCTION SYNDROME CAUSED BY IL-2 INFUSION PRIOR TO ANTI-GD2 ANTIBODY IMMUNOTHERAPY FOR NEUROBLASTOMA: CASE REPORT
    Inoue, Shotaro
    Mori, Takeshi
    Hyodo, Sayaka
    Uemura, Suguru
    Saito, Atsuro
    Kozaki, Aiko
    Kishimoto, Kenji
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [39] Copper chelation overcomes the immunosuppressive neuroblastoma microenvironment to potentiate anti-GD2 antibody therapy
    Rouaen, Jourdin R.
    Salerno, Antonella
    Luciani, Fabio
    Murray, Jayne
    Shai-Hee, Tyler
    Tedla, Nicodemus
    Haber, Michelle
    Trahair, Toby N.
    Vittorio, Orazio
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Spinal nerve roots contrast enhancement following anti-GD2 antibody therapy in neuroblastoma
    Morana, Giovanni
    Lanteri, Paola
    Tortora, Domenico
    Martinetti, Carola
    Garaventa, Alberto
    NEUROLOGY, 2018, 90 (19) : 895 - 896
12345